197 related articles for article (PubMed ID: 32475830)
1. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic.
Fragoulis GE; Evangelatos G; Arida A; Bournia VK; Fragiadaki K; Karamanakos A; Kravvariti E; Laskari K; Panopoulos S; Pappa M; Tektonidou MG; Sfikakis PP
Ann Rheum Dis; 2021 Apr; 80(4):e60. PubMed ID: 32475830
[No Abstract] [Full Text] [Related]
2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis
Schulze-Koops H; Krueger K; Specker C
Ann Rheum Dis; 2021 Apr; 80(4):e61. PubMed ID: 32475833
[No Abstract] [Full Text] [Related]
3. Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease.
Robinson PC; Kim AHJ
Best Pract Res Clin Rheumatol; 2021 Mar; 35(1):101664. PubMed ID: 33610466
[No Abstract] [Full Text] [Related]
4. COVID-19, rheumatic diseases and immune dysregulation-a perspective.
Tariq S; Van Eeden C; Tervaert JWC; Osman MS
Clin Rheumatol; 2021 Feb; 40(2):433-442. PubMed ID: 33411143
[TBL] [Abstract][Full Text] [Related]
5. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
Ferri C; Giuggioli D; Raimondo V; L'Andolina M; Dagna L; Tavoni A; Caso F; Ursini F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; Abignano G; De Santis M; Lubrano E; Fusaro E; Rossa AD; Spinella A; Lumetti F; De Luca G; Bellando-Randone S; Visalli E; Dal Bosco Y; Amato G; Giannini D; Bilia S; Masini F; Pellegrino G; Pigatto E; Generali E; Mariano GP; Pettiti G; Zanframundo G; Brittelli R; Aiello V; Caminiti R; Scorpiniti D; Ferrari T; Campochiaro C; Brusi V; Fredi M; Moschetti L; Cacciapaglia F; Gragnani L; Monti M; Lorini S; Paparo SR; Ragusa F; Mazzi V; Elia G; Ferrari SM; Di Cola I; Vadacca M; Lorusso S; Barsotti S; Aprile ML; Marco T; Miccoli M; Bosello S; Matucci-Cerinic M; D'Angelo S; Doria A; Franceschini F; Meliconi R; Iannone F; Giacomelli R; Zignego AL; Fallahi P; Antonelli A
Curr Pharm Des; 2021; 27(41):4245-4252. PubMed ID: 34477509
[TBL] [Abstract][Full Text] [Related]
6. Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: A survey in 644 rheumatic patients.
López-Medina C; Ladehesa-Pineda L; Gómez-García I; Puche-Larrubia MÁ; Sequí-Sabater JM; Armenteros-Ortiz P; Ortega-Castro R; Garrido-Castro JL; Escudero-Contreras A; Collantes-Estévez E
Joint Bone Spine; 2021 Mar; 88(2):105085. PubMed ID: 33127460
[No Abstract] [Full Text] [Related]
7. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
[TBL] [Abstract][Full Text] [Related]
8. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
Dejaco C; Bijlsma JW; Buttgereit F
Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
[No Abstract] [Full Text] [Related]
9. COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic.
Akintayo RO; Akpabio A; Kalla A; Dey D; Migowa A; Olaosebikan H; Bahiri R; El Miedany Y; Hadef D; Hamdi W; Oyoo O; Slimani S; Yerima A; Taha Y; Adebajo A; Adelowo O; Tikly M; Ghozlani I; Abdelghani KB; Fouad NA; Mosad D; El Mikkawy D; Abu-Zaid MH; Abdel-Magied RA;
Ann Rheum Dis; 2021 Jun; 80(6):e100. PubMed ID: 32611599
[No Abstract] [Full Text] [Related]
10. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic
Schulze-Koops H; Krueger K; Specker C;
Ann Rheum Dis; 2021 Jun; 80(6):e86. PubMed ID: 32576567
[No Abstract] [Full Text] [Related]
11. COVID-19 and mortality in rare rheumatic diseases, a warning bell?
Galloway J; Bukhari M
Rheumatology (Oxford); 2021 Apr; 60(4):1580-1581. PubMed ID: 33410464
[No Abstract] [Full Text] [Related]
12. Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience.
Pineda-Sic RA; Galarza-Delgado DA; Serna-Peña G; Castillo-Torres SA; Flores-Alvarado DE; Esquivel-Valerio JA; Hernández-Galarza IJ
Ann Rheum Dis; 2021 Jun; 80(6):e85. PubMed ID: 32576568
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
[TBL] [Abstract][Full Text] [Related]
14. Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study.
Fragoulis GE; Grigoropoulos I; Mavrea E; Arida A; Bournia VK; Evangelatos G; Fragiadaki K; Karamanakos A; Kravvariti E; Panopoulos S; Pappa M; Thomas K; Tektonidou MG; Paraskevis D; Vassilopoulos D; Sfikakis PP
Rheumatol Int; 2021 May; 41(5):895-902. PubMed ID: 33661331
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco.
Wafa A; Hicham H; Hajar K; Mouna M; Zoubida MT; Mohamed A
Pan Afr Med J; 2020; 37():240. PubMed ID: 33552358
[No Abstract] [Full Text] [Related]
16. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
Al Nokhatha S; MacEoin N; Conway R
Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
[No Abstract] [Full Text] [Related]
17. Education and treatment adherence during the COVID-19 pandemic. Response to: 'Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic' by Khabbazi
Pineda-Sic RA; Serna-Peña G; Cardenas-de la Garza JA; Torres-Castillo SA; Galarza-Delgado DA; Flores-Alvarado DE
Ann Rheum Dis; 2022 Oct; 81(10):e201. PubMed ID: 32895238
[No Abstract] [Full Text] [Related]
18. Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.
Gupta L; Misra DP; Agarwal V; Balan S; Agarwal V
Ann Rheum Dis; 2021 Jan; 80(1):e1. PubMed ID: 32299795
[No Abstract] [Full Text] [Related]
19. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
20. Increasing autoimmune rheumatic diseases as a consequence of the COVID-19 pandemic: A hypothesis or fact?
Baimukhamedov C; Togizbayev G; Mirakhmedova K; Mamasaidov A; Shukurova S
Int J Rheum Dis; 2024 Jan; 27(1):e15011. PubMed ID: 38140787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
